Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Isotope & RadiationHKSE:01763 -1.88%92 Quick Ratio is 1.51 as of Dec. 2025, which is 11% below its 10-year median of 1.69. GuruFocus rates HKSE:01763 with a GF Score™ of 92/100 and a GF Value™ of HK$15.74 (Fairly Valued). The stock has 5 warning signs investors should review. Among 851 Medical Devices & Instruments companies, China Isotope & Radiation ranks worse than 60.63% on this metric.
China Isotope & Radiation has a quick ratio of 1.51. It generally indicates good short-term financial strength.
The historical rank and industry rank for China Isotope & Radiation's Quick Ratio or its related term are showing as below:
HKSE:01763'
s Quick Ratio Range Over the Past 10 Years
Min: 1.2 Med: 1.69 Max: 2.07
Current: 1.51
During the past 11 years, China Isotope & Radiation's highest Quick Ratio was 2.07. The lowest was 1.20. And the median was 1.69.
HKSE:01763's Quick Ratio is ranked worse than 60.63% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 1.86
vs HKSE:01763: 1.51
China Isotope & Radiation (HKSE:01763) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
China Isotope & Radiation Quick Ratio Related Terms
China Isotope & Radiation Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01763 vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, China Isotope & Radiation's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Quick Ratio distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
China Isotope & Radiation's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Isotope & Radiation (HKSE:01763) has a Quick Ratio of 1.51 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on China Isotope & Radiation and its competitors. This is 11% below median its historical median of 1.69. Over the past decade, China Isotope & Radiation's Quick Ratio has ranged from 1.20 to 2.07. According to the industry distribution chart, China Isotope & Radiation ranks #516 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 60.6%.
Is China Isotope & Radiation's Quick Ratio too high?
China Isotope & Radiation's current Quick Ratio of 1.51 is 11% below median its 10-year median of 1.69. Over the past 10 years, this metric has ranged from a low of 1.20 to a high of 2.07. The Medical Devices & Instruments industry median Quick Ratio is 1.86. China Isotope & Radiation's value of 1.51 is 18.8% below this industry median. Based on the distribution chart, China Isotope & Radiation ranks #516 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, China Isotope & Radiation has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Isotope & Radiation's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, China Isotope & Radiation ranks #516 out of 851 companies for Quick Ratio. This places China Isotope & Radiation in the lower half of its industry. The industry median Quick Ratio is 1.86. China Isotope & Radiation's value of 1.51 is 18.8% below this benchmark. Historically, China Isotope & Radiation's own Quick Ratio has ranged from 1.20 to 2.07 over the past decade. While the company's 10-year median is 1.69 vs. the industry median of 1.86, China Isotope & Radiation has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.86, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Isotope & Radiation's current Quick Ratio of 1.51 is 18.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on China Isotope & Radiation and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Isotope & Radiation's current Quick Ratio is 1.51, which is 11% below median its own 10-year median of 1.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Isotope & Radiation stock overvalued right now?
Based on GuruFocus' analysis, China Isotope & Radiation (HKSE:01763) is currently considered Fairly Valued. The stock's GF Value™ is HK$15.74, compared to a current price of HK$16.70 — trading 6.1% above its estimated fair value. The current Quick Ratio is 1.51, which is 11% below median its 10-year median of 1.69 and 18.8% below the Medical Devices & Instruments industry median of 1.86. China Isotope & Radiation's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For China Isotope & Radiation (HKSE:01763), the current Quick Ratio is 1.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Isotope & Radiation (HKSE:01763) Overvalued in 2026?
Based on GuruFocus' analysis, China Isotope & Radiation stock appears to be overvalued.
The current stock price of HK$16.70 is trading 6.1% above its estimated GF Value™ of HK$15.74.
GuruFocus considers China Isotope & Radiation to be Fairly Valued.
Key valuation signals for HKSE:01763:
Quick Ratio: 1.51 (11% below median its 10-year median of 1.69)
GF Value™: HK$15.74 vs. price of HK$16.70 (6.1% above fair value)
Industry Position: 18.8% below the Medical Devices & Instruments median (#516 of 851)
No single metric tells the full story. See the HKSE:01763 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: (1) nuclear medicine; (2) radioactive source products; (3) irradiation; (4) nuclear medical equipment and related services; and (5) other businesses. Nuclear medicines: manufacturing and sale of a range of imaging diagnostic and therapeutic radio pharmaceuticals imaging, UBT diagnostic kits and test analysers and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
92GF Score
Get the complete analysis for HKSE:01763
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01763 has been successfully added to your 
